![Jian Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jian Lin
Director/Board Member at
Remegen Biosciences, Inc.
Net worth: 154 814 $ as of 31/07/2026
Profile
Jian Lin is currently Director at Remegen Biosciences, Inc. and Director at Ruimeijing Beijing Pharmaceutical Technology Co. Ltd. Formerly, Mr. Lin was Executive Director at RemeGen Co., Ltd. from 2020 to 2026.
Mr. Lin completed an undergraduate degree at Harbin University of Commerce in 1982.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2026 | 14,850 ( 0.01% ) | 154 814 $ | 31/07/2026 |
Jian Lin active positions
| Companies | Position | Start |
|---|---|---|
Remegen Biosciences, Inc.
 Remegen Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceutical therapies for cancer & autoimmune diseases | Director/Board Member | - |
Ruimeijing Beijing Pharmaceutical Technology Co. Ltd. | Director/Board Member | - |
Former positions of Jian Lin
| Companies | Position | End |
|---|---|---|
| REMEGEN CO., LTD. | Director/Board Member | 16/06/2026 |
Training of Jian Lin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Harbin University of Commerce
 Harbin University of Commerce Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RemeGen Co., Ltd.
 RemeGen Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer drugs | Health Technology |
Remegen Biosciences, Inc.
Remegen Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceutical therapies for cancer & autoimmune diseases | Commercial Services |
Ruimeijing Beijing Pharmaceutical Technology Co. Ltd. |
- Stock Market
- Insiders
- Jian Lin
